Home/ Supplements/ Alpha Lipoic Acid/ Syntha Phase Cookies & Cream

Syntha Phase Cookies & Cream

product on market Powder Precision Engineered Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 47% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product primarily provides protein and carbohydrates, which are supported by strong evidence for supporting muscle protein synthesis and energy replenishment. These macronutrients are well-established in nutritional research for supporting athletic recovery. The ingredient profile is generally recognized as safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Syntha Phase Cookies & Cream
Open Full PDF View on NIH DSLD →
Details

Label Data

46 Gram(s)
Serving Size
29
Servings
Other Combinations
Product Type
47%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
180 Calorie(s)
Total Fat
3.5 Gram(s) (5% DV)
Cholesterol
50 mg (17% DV)
Total Carbohydrates
11 Gram(s) (4% DV)
Protein
24 Gram(s) (47% DV)
Vitamin A
800 IU (16% DV)
Vitamin C
12 mg (20% DV)
80 IU (20% DV)
Within RDA (0.1× RDA) 608 studies (A:16, B:251)
12 IU (40% DV)
Within RDA (0.5× RDA) 179 studies (A:3, B:90)
0.3 mg (20% DV)
Within RDA (0.2× RDA) 76 studies (A:0, B:33)
0.34 mg (20% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:1)
4 mg (20% DV)
Within RDA (0.3× RDA) 196 studies (A:5, B:63)
0.4 mg (20% DV)
Within RDA (0.3× RDA) 114 studies (A:3, B:35)
80 mcg (20% DV)
Within RDA (0.2× RDA) 226 studies (A:10, B:105)
1.2 mcg (20% DV)
Within RDA (0.5× RDA) 139 studies (A:1, B:44)
60 mcg (20% DV)
2.0× RDA — within safe limits 27 studies (A:0, B:11)
2 mg (20% DV)
Within RDA (0.4× RDA) 2 studies — no high-quality reviews
Calcium
285 mg (29% DV)
Iron
4 mg (22% DV)
283 mg (28% DV)
Within RDA (0.4× RDA) 13 studies (A:0, B:3)
30 mcg (20% DV)
Within RDA (0.2× RDA) 245 studies (A:4, B:133)
86 mg (22% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
3 mg (20% DV)
Within RDA (0.3× RDA) 263 studies (A:6, B:134)
10 mcg (14% DV)
Within RDA (0.2× RDA) 173 studies (A:0, B:67)
0.4 mg (20% DV)
Within RDA (0.4× RDA) 37 studies (A:0, B:11)
0.8 mg (40% DV)
Within RDA (0.3× RDA) 9 studies — no high-quality reviews
40 mcg (33% DV)
1.1× RDA — within safe limits 199 studies (A:1, B:55)
21 mcg (28% DV)
Within RDA (0.5× RDA) 3 studies — no high-quality reviews
Sodium
105 mg (4% DV)
Potassium
190 mg (5% DV)
2500 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
1786 mg
Market median: 420.0mg (227 products)
1539 mg
Market median: 500.0mg (143 products)
15 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Cinnamon
10 mg
Papain
5 mg
3.8 mg
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)

Other Ingredients

Whey Protein concentrate Maltodextrin Soy Protein isolate Flaxseed Non-Dairy Creamer L-Glutamine L-Arginine Calcium Caseinate Milk Protein isolate Natural and Artificial flavors Vitamin and Mineral Blend Cookie Crumbs Micellar Casein Milk Protein concentrate Carrageenan Oat Fiber Medium Chain Triglycerides Corn Starch Acesulfame Potassium Sucralose Bromelain Cinnamon Alpha Lipoic Acid Whey Protein Isolate dried Egg White Papain
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Use in conjunction with an intense daily exercise program and a balanced diet including an adequate caloric intake.

DIRECTIONS: For adults, blend one (1) scoop (46 g) of powder with 8 oz. of cold water or nonfat milk. Mix in your Precision Engineered shaker or a blender and drink immediately for best results. You can drink Precision Engineered Syntha Phase any time during the day when you need complete protein support, especially when you may not be able to ingest protein as often as you'd like. Increase or decrease the amount of liquid added to achieve desired consistency.

Warnings & Precautions

WARNING: Not intended for use by pregnant or nursing women. If you are taking any medications, planning any medical or surgical procedure or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Not intended for use by persons under the age of 18. Keep out of reach of children.

Do not use if seal under cap is broken or missing.

Contents are sold by weight. Some settling may occur.

NOTICE: Use this product as a food supplement only. Do not use for weight reduction.

Contains milk, wheat, egg and soy ingredients.

Formulation Notes

No Artificial Color, No Fish.

Syntha Phase Features: Over 4 grams of naturally occurring BCAAs from protein to help support protein metabolism* Isoleucine 1.3 g Leucine 2.3 g Valine 1.3 g 24 grams of Protein with high quality whey to support exercise recovery* Amino Acids. such as Glutamine provide the fuel your body needs to get the most from your workouts*

24 g Protein with High Quality Whey for Muscle & Strength

97% Lactose-Free

Contains milk, wheat, egg and soy ingredients.

Additional Information

Precision Engineered has pioneered the manufacture of premium sports nutrition supplements. Our commitment to quality is the highest in our industry. Every product undergoes rigorous analysis for purity, potency, safety and freshness. We guarantee it.

QA QUALITY ASSURED

Syntha Phase is designed for superior nutritional support. A combination of 25 essential vitamins and minerals with whey protein provide nutritional support for your workouts.* Eliminates the need for stacking because Syntha Phase contains all of the nutrients you need in one easy-to-use nutritional supplement.

Store at room temperature.

PROD. #35729 B64646 03A

Synergistic Nutritional Support

25 Essential Vitamins & Minerals

NATURALLY & ARTIFICIALLY FLAVORED

Amino Acids (approximate values) per serving (46 g): L-Alanine 998 mg L-Arginine 2,428 mg L-Aspartic Acid 2,530 mg L-Cysteine 423 mg L-Glutamic Acid 5,515 mg L-Glycine 542 mg ****L-Histidine 561 mg ****L-Isoleucine 1,315 mg ****L-Leucine 2,346 mg ****L-Lysine 1,959 mg ****L-Methionine 492 mg ****L-Phenylalanine 887 mg L-Proline 1,444 mg L-Serine 1,311 mg ****L-Threonine 1,568 mg ****L-Tryptophan***** 368 mg L-Tyrosine 777 mg ****L-Valine 1,311 mg ****Essential Amino Acids *****L-Tryptophan is naturally occurring, not added.

Metadata

Product Details

UPC / SKU7 66443 35729 2
DSLD Entry Date2016-07-25
Product TypeOther Combinations
FormPowder
DSLD ID63134
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.